Piperacillin/Tazobactam: Difference between revisions
(Text replacement - "piperacillin/tazobactam " to "piperacillin/tazobactam") |
(Complications and Pharmacology) |
||
Line 62: | Line 62: | ||
==Contraindications== | ==Contraindications== | ||
*Allergy to class/drug | *Allergy to class/drug | ||
*Caution | |||
**Non-anaphylactic hypersensitivity to beta-lactams | |||
**Asthma | |||
**Cystic fibrosis | |||
**Recent abx-associated colitis | |||
**Seizure disorder | |||
**Renal impairement | |||
**Sodium restriction | |||
**Hypokalemia | |||
**Bleeding risk | |||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*[[Anaphylaxis]] | |||
*Serum sickness-like reaction | |||
*Drug reaction w/ eosinophilia and systemic sx | |||
*Acute generalized exanthematous pustulosis | |||
*Erythema multiforme | |||
*[[Stevens-Johnson Syndrome]] | |||
*Toxic epidermal necrosis | |||
*Interstitial nephritis | |||
*Superinfection | |||
*C. difficile associated [[diarrhea]] | |||
*[[Hemolytic anemia]] | |||
*[[Leukopenia]] | |||
*[[Neutropenia]] | |||
*[[Pancytopenia]] | |||
*Agranulocytosis | |||
*[[Thrombocytopenia]] | |||
*Bleeding | |||
*[[Hypokalemia]] | |||
*[[Seizure]] | |||
===Common=== | ===Common=== | ||
*[[Diarrhea]] | |||
*[[Headache]] | |||
*[[Constipation]] | |||
*[[Nausea]] | |||
*Insomnia | |||
*Rash | |||
*[[Vomiting]] | |||
*Dyspepsia | |||
*Pruritus | |||
*[[Fever]] | |||
*Agitation | |||
*Electrolyte abnormality | |||
*LFT elevation | |||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: | *Half-life: | ||
**Pipercillin: 30-90 min | |||
**Tazobactam: 0.7-1.2h | |||
*Metabolism: | *Metabolism: | ||
**Pipercillin: Liver minimally | |||
**Tazobactam: Liver | |||
*Excretion: | *Excretion: | ||
**Pipercillin: Urine 68% | |||
**Tazobactam: Urine primarily | |||
*Mechanism of Action: | *Mechanism of Action: | ||
**Pipercillin: Inhibits cell wall mucopeptide synthesis | |||
**Tazobactam: Inhibits beta-lactamases | |||
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== |
Revision as of 06:07, 17 August 2017
General
- Type: Anti-Pseudomonal Penicillin
- Dosage Forms: 2.25gm vial, 3.375gm vial, 4.5gm vial, 40.5gm bulk bottle (Powder for reconstitution)
- Common Trade Names: Zosyn
Adult Dosing
General
- 3.375 g IV q6 hours
- Alt: 4.5 g q6-8 hours
- Max: 18 g/day
Extended Interval Dosing
- 3.375 g IV infused over 4 hours q8 hours
Diverticulitis
- 3.375 g IV q6 hours x 7-10 days
Pneumonia
- CAP
- 3.375 g IV q6 hours x 7-10 days
- Only for P. aeruginosa caused or from aspiration[3]
- Nosocomial
- 4.5 g IV q6 hours or 3.375 g IV q4 hours x 7-14 days
- + aminoglycoside or antipseudomonal fluoroquinolone
Pediatric Dosing[4]
A Piperacillin/Taxobactam 3.375g vial contains 3g piperacillin and 0.375g tazobactam (8:1 ratio)
General
- <2 months
- 100mg piperacillin/kg/dose IV q6 hours
- 2-9 months
- 80mg piperacillin/kg/dose IV q8 hours
- >9 months
- 100mg piperacillin/kg/dose q8 hours
- Max: 16 g/day
Appendicitis and/or Peritonitis
- 2-9 months
- 80mg piperacillin/kg/dose IV q8 hours
- >9 months
- ≤40 kg: 100mg piperacillin/kg/dose IV q8 hours
- >40 kg: 3.375g (3000mg piperacillin) IV q6 hours
- Max: 16 g/day
Cystic Fibrosis, Pseudomonal Infection
- 240-400mg piperacillin/kg/day IV divided q8 hours;
- Consider higher dose: 450-600mg/kg/day IV divided q4-6 hours[5]
Special Populations
- Pregnancy:
- Lactation:
- Renal Dosing
- Hepatic Dosing - no change
Contraindications
- Allergy to class/drug
- Caution
- Non-anaphylactic hypersensitivity to beta-lactams
- Asthma
- Cystic fibrosis
- Recent abx-associated colitis
- Seizure disorder
- Renal impairement
- Sodium restriction
- Hypokalemia
- Bleeding risk
Adverse Reactions
Serious
- Anaphylaxis
- Serum sickness-like reaction
- Drug reaction w/ eosinophilia and systemic sx
- Acute generalized exanthematous pustulosis
- Erythema multiforme
- Stevens-Johnson Syndrome
- Toxic epidermal necrosis
- Interstitial nephritis
- Superinfection
- C. difficile associated diarrhea
- Hemolytic anemia
- Leukopenia
- Neutropenia
- Pancytopenia
- Agranulocytosis
- Thrombocytopenia
- Bleeding
- Hypokalemia
- Seizure
Common
- Diarrhea
- Headache
- Constipation
- Nausea
- Insomnia
- Rash
- Vomiting
- Dyspepsia
- Pruritus
- Fever
- Agitation
- Electrolyte abnormality
- LFT elevation
Pharmacology
- Half-life:
- Pipercillin: 30-90 min
- Tazobactam: 0.7-1.2h
- Metabolism:
- Pipercillin: Liver minimally
- Tazobactam: Liver
- Excretion:
- Pipercillin: Urine 68%
- Tazobactam: Urine primarily
- Mechanism of Action:
- Pipercillin: Inhibits cell wall mucopeptide synthesis
- Tazobactam: Inhibits beta-lactamases
Antibiotic Sensitivities[8]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
See Also
References
- ↑ Shea KM, Cheatham SC, Smith DW, Wack MF, Sowinski KM, Kays MB. Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactamusing Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients. Ann Pharmacother. 2009;43(11):1747-54.
- ↑ Kaufman SE, Donnell RW, Hickey WS. Rationale and evidence for extended infusion of piperacillin-tazobactam. Am J Health Syst Pharm. 2011 Aug 15;68(16):1521-6.
- ↑ Mandell, 2007
- ↑ Red Book, 2012
- ↑ Zobell JT, Waters CD, Young DC, et al, "Optimization of Anti-Pseudomonal Antibiotics for Cystic Fibrosis Pulmonary Exacerbations: II. Cephalosporins and Penicillins," Pediatr Pulmonol, 2013, 48(2):107-22. PubMed 22949297
- ↑ GlobalRPH. Piperacillin/Tazobactam - Zosyn® - Renal Dosing. http://www.globalrph.com/piperacillin-tazobactam_renal.htm
- ↑ Epocrates. Zosyn - Entire Monograph. https://online.epocrates.com/u/10a1657/Zosyn
- ↑ Sanford Guide to Antimicrobial Therapy 2014